| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |